Nama Insights

Clorox (CLX)

Consumer Defensive · Household Personal Products · NYSE

S&P 500
Clorox (CLX) is a Consumer Defensive company in the Household Personal Products industry. It has a market capitalization of $12.09B, a trailing price-to-earnings ratio of 16.0 and a free-cash-flow yield of 3.3%. Over the most recent reported fiscal year, revenue declined 5.3% and free cash flow per share fell 14.3%. Nama's AI scorecard rates it Hold, 4.4 out of 10. On 12-month momentum it ranks in the trailing band of its market.
AI scorecard
Hold · 4.4/10
The sections balance. As of Nov 7, 2026.
Momentum
Trailing · -22.6% over 12 months ex. last
Bottom 20% of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-46.5%
How far the last close sits under the highest price of the past five years.
Market cap$12.09B
Trailing P/E16.0
Price / book135.1
Price / sales1.8
FCF yield3.3%
Dividend yield5.0%
Gross margin42.3%
Operating margin13.2%
Net margin8.7%
Revenue growth (YoY)-5.3%
Revenue growth (3-yr annual)—
EPS growth (YoY)-10.4%
FCF/share growth (YoY)-14.3%
Beta0.6
ExchangeNYSE
SectorConsumer Defensive
IndustryHousehold Personal Products

CLX earnings

Next report: Feb 2, 2027 (Q2 2027, EPS estimate $1.07). Beat the EPS estimate in 3 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q1 2027 Nov 2, 2026 $1.55 $1.07 +44.9% $1.91B
Q4 2026 Aug 3, 2026 $1.66 $1.65 +0.6% $1.95B
Q3 2026 Apr 30, 2026 $1.64 $1.54 +6.5% $1.67B
Q2 2026 Feb 3, 2026 $1.39 $1.43 -2.8% $1.67B

CLX analyst price target

Median target $96.00 from 17 analysts, ranging $74.00 – $154.00.

Household Personal Products peers

TickerCompanyMarket capP/E
PG Procter & Gamble $383.36B 24.0
UL Unilever $142.12B 44.0
CL Colgate-Palmolive $76.76B 24.9
KMB Kimberly-Clark $66.54B 14.2
EL Estée Lauder Companies $39.88B 37.8
KVUE Kenvue $37.11B 16.2
CHD Church & Dwight $25.81B 30.2
ELF e.l.f. Beauty $6.86B 25.7
Explore live CLX data on Nama Insights →

Recent Congressional trades

Clorox trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Gilbert Cisneros House Sell $1,001 - $15,000 Jun 8, 2026
Gilbert Cisneros House Buy $1,001 - $15,000 Jan 12, 2026
Gilbert Cisneros House Sell $1,001 - $15,000 Dec 15, 2025
Lisa McClain House Sell $1,001 - $15,000 Nov 21, 2025
Lisa McClain House Sell $1,001 - $15,000 Nov 21, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
Jefferson Shreve House Sell $15,001 - $50,000 May 8, 2025
Ron L Wyden Senate Sell $1,001 - $15,000 —
Ron L Wyden Senate Buy $1,001 - $15,000 —
David A Perdue , Jr Senate Sell $1,001 - $15,000 —
David A Perdue , Jr Senate Sell $1,001 - $15,000 —
Shelley M Capito Senate Buy $1,001 - $15,000 —

CLX FAQ

Is CLX a buy?
Nama's AI scorecard currently rates Clorox Hold (4.4 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CLX's P/E ratio?
Clorox trades at a trailing price-to-earnings ratio of 16.0.
When does CLX report earnings?
Clorox's next scheduled report is on Feb 2, 2027. Analysts expect EPS of $1.07.
What is the CLX price target?
The median analyst price target from 17 analysts is $96.00, with a range of $74.00 – $154.00.
Is CLX Shariah compliant?
Nama's AAOIFI-style screen reads Clorox as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does CLX pay a dividend?
Yes — Clorox's dividend yield is 5.0%.